openPR Logo
Press release

Digital Diabetes Management Market Set for Strong Growth to US$ 38.37 Billion by 2033, Led by North America's 38.2% Market Share | Key Players - Abbott, Dexcom, Inc., F. Hoffmann-La Roche Ltd

02-09-2026 11:24 AM CET | Health & Medicine

Press release from: DataM intelligence 4 Market Research LLP

Digital Diabetes Management Market

Digital Diabetes Management Market

The Digital Diabetes Management Market reached US$ 16.58 billion in 2024 and is expected to reach US$ 38.37 billion by 2033, growing at a CAGR of 10.3% during the forecast period 2025-2033.

Market growth is driven by the surging global prevalence of diabetes, widespread adoption of continuous glucose monitoring (CGM) devices, and the integration of AI-powered apps for personalized insulin dosing and lifestyle coaching. Advancements in wearable biosensors, expanding telehealth platforms for remote patient monitoring, rising investments in digital therapeutics, and supportive regulatory frameworks for connected health devices are further accelerating market expansion.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/digital-diabetes-management-market?ram

Key Industry Developments

United States:
✅ January 2026: Dexcom launched the G8 Continuous Glucose Monitor with enhanced AI-driven predictive alerts and extended 14-day sensor wear, improving real-time glucose forecasting and integration with popular insulin pumps for automated adjustments in Type 1 diabetes patients.

✅ December 2025: Medtronic introduced the MiniMed 880G system upgrade featuring Guardian 5 sensor technology with smartphone app connectivity for remote data sharing, enabling family caregivers and physicians to monitor trends via cloud platform.

✅ November 2025: Abbott unveiled FreeStyle Libre 4, the world's smallest CGM with 15-day wear and no fingersticks, featuring Bluetooth-enabled real-time alarms and optional over-the-counter availability for adults.

Asia Pacific / Japan:
✅ January 2026: Omron Healthcare Japan released the Complete Smart Blood Glucose Monitor with AI analytics and telehealth linkage, supporting remote consultations via Japan's national health network for elderly patients.

✅ December 2025: Terumo Corporation launched the PocketGlu Neo digital glucometer in Japan and APAC markets, featuring NFC data transfer to EHR systems and voice-guided testing for low-vision users.

✅ November 2025: Nipro Asia-Pacific introduced the Trueyou CGM patch with 10-day continuous monitoring and app-based bolus calculator, approved by Japan PMDA and rolled out across Southeast Asia.

Strategic Mergers and Acquisitions:
✅ Glooko acquired Monarch Medical Technologies in September 2025, expanding its diabetes digital health platform into inpatient glycemic management with the EndoTool Glucose Management System to enable comprehensive connected care from hospitals to outpatient settings.

✅ Tandem Diabetes Care acquired algorithm specialist Sugarmate in 2025, integrating its real-time data engine to enhance competitive differentiation through advanced data layers in the digital diabetes management market.

Key Players:
Abbott | Dexcom, Inc. | F. Hoffmann-La Roche Ltd | Medtronic | Insulet Corporation | Tandem Diabetes Care, Inc. | Ascensia Diabetes Care Holdings AG | LifeScan IP Holdings, LLC | AgaMatrix | Ypsomed AG

Strategic Leadership Report: Top 5 Players in Digital Diabetes Management Market 2026
-Abbott: Integrated FreeStyle Libre CGM system with Insulet's Omnipod Horizon automated insulin delivery, enabling seamless glucose data transfer for personalized insulin adjustments via smartphone app without additional devices.

-Dexcom, Inc.: Launched Dexcom G7 CGM with enhanced real-time glucose monitoring and direct smartphone integration, featuring improved accuracy, predictive alerts for hypoglycemia, and simplified 10-day wear for streamlined diabetes management.

-F. Hoffmann-La Roche Ltd: Advanced Accu-Chek SmartGuide CGM solution with AI-driven glucose trend predictions and bolus calculator integration, providing proactive insights to reduce variability and support hybrid closed-loop therapy.

-Medtronic: Upgraded MiniMed 780G system with SmartGuard technology for automated insulin delivery, incorporating meal detection and exercise adaptability to minimize user intervention and optimize glycemic control in dynamic lifestyles.

-Insulet Corporation: Introduced Omnipod 5 automated insulin delivery system with enhanced algorithms for personalized basal rates and correction boluses, integrating CGM data for tubeless, app-controlled management reducing daily burdens.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=digital-diabetes-management-market?ram

Market Drivers and Key Trends:
-Rising Diabetes Prevalence: Global surge in diabetes cases, affecting over 500 million adults, fuels demand for scalable digital monitoring and management solutions.

-Smartphone Penetration: Widespread adoption of smartphones and health apps enables real-time glucose tracking and remote patient monitoring worldwide.

-AI Integration Advances: AI, machine learning, and predictive analytics deliver personalized insulin dosing and glycemic predictions via CGM systems.

-Technological Innovations: Continuous glucose monitors (CGM), smart insulin pens, and hybrid closed-loop pumps enhance accuracy and user-centric care.

-Home Healthcare Shift: Growing preference for convenient at-home solutions reduces hospitalizations and supports aging populations.

-Market Hurdles: High device costs, reimbursement gaps in emerging markets, data privacy risks, and low awareness in developing regions constrain expansion.

Regional Insights:
-North America: 38.2% (Largest share, driven by high adoption of connected devices and favorable reimbursement policies).

-Asia Pacific: Expected fastest growth at 10.2% CAGR (Fueled by rising diabetes prevalence in China and India, plus improving healthcare infrastructure).

-Europe: Second-largest position (Supported by digital health promotions, startups, and steady diabetes management investments).

Digital Diabetes Management Market Opportunities & Challenges: 2026
Digital diabetes management solutions, including CGM devices, smart apps, and telehealth platforms, continue rapid expansion amid rising global diabetes prevalence and tech adoption.

-Opportunities
A "CGM Accessibility Surge" accelerates growth, with smartphone-integrated systems projecting a 22.5% CAGR to $17.1B by 2026. mHealth platforms in emerging Asia-Pacific markets like India (23.5% CAGR) enable scalable remote monitoring for underserved populations.

-Challenges
Data privacy regulations intensify scrutiny on connected devices, while high upfront costs and reimbursement gaps in developing regions limit adoption. Interoperability issues across fragmented ecosystems demand standardized APIs for seamless integration.

-Strategic Verdict
AI-enhanced predictive analytics and hybrid closed-loop systems will dominate 2026 growth, prioritizing personalized care in high-prevalence regions.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/digital-diabetes-management-market?ram

Market Segmentation Analysis:
-By Product & Service: Digital Apps Dominate User Engagement
Digital diabetes management apps lead with 45% share in 2025, offering real-time glucose tracking, personalized coaching, and integration with CGMs for convenient self-management.
Devices follow at 30%, including glucometers and insulin pumps for accurate monitoring and automated delivery.
Data management software & platforms hold 20%, enabling cloud-based analytics and telehealth insights for providers.
Others capture 5%, covering teleconsultation and coaching services.

-By Device Type: Wearables Surge in Continuous Monitoring
Wearable devices command 60% share, prized for non-invasive CGM and real-time alerts enhancing lifestyle integration.
Handheld devices take 40%, valued for portability in SMBG but limited by manual testing needs.

-By End-User: Self/Home Healthcare Prevails for Empowerment
Self/home healthcare dominates at 55% share, driven by patient-centric tech adoption and remote monitoring trends.
Hospitals & specialty diabetes clinics hold 25%, focusing on inpatient diagnostics and therapy optimization.
Academic & research institutes account for 15%, advancing innovation trials.
Others claim 5%, including payers and corporates.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?ram

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTW

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Digital Diabetes Management Market Set for Strong Growth to US$ 38.37 Billion by 2033, Led by North America's 38.2% Market Share | Key Players - Abbott, Dexcom, Inc., F. Hoffmann-La Roche Ltd here

News-ID: 4382341 • Views:

More Releases from DataM intelligence 4 Market Research LLP

Methacrylate Monomers Market is expected to reach USD 18.12 billion by 2032 with a CAGR of 5.0%, Dominate by Asia Pacific 45% market share
Methacrylate Monomers Market is expected to reach USD 18.12 billion by 2032 with …
The global Methacrylate Monomers Market size was valued at USD 12.34 billion in 2024 and is expected to reach USD 18.12 billion by 2032, at a CAGR of 5.0% during the forecast period of 2024-2032. The Methacrylate Monomers Market is growing due to rising demand for lightweight plastics, coatings, and adhesives, expanding construction and automotive sectors, and innovations in durable, high-performance polymer applications. Get a Free Sample PDF Of This Report (Get
United States EV Charging Stations Market to Reach US$ 41.22 Billion by 2030 | North America leads with 35% share | Top Companies - Tesla Supercharger Network, Charging point, ABB limited
United States EV Charging Stations Market to Reach US$ 41.22 Billion by 2030 | N …
Leander, Texas and Tokyo, Japan - Feb.09.2026 As per DataM intelligence research report "Global EV Charging Station Market reached US$ 22.9 billion in 2022 and is expected to reach US$ 137.4 billion by 2030 growing with a CAGR of 25.3% during the forecast period 2024-2031." Growth is fueled by rapid electric vehicle adoption and government decarbonization policies. Public and fast-charging stations dominate deployment. Urban infrastructure and highway networks drive demand. Incentives, grid
Humanoid Robot Market to Reach US$ 41.02 Billion by 2032 at 43.83% CAGR | North America Leads with 34% Share
Humanoid Robot Market to Reach US$ 41.02 Billion by 2032 at 43.83% CAGR | North …
Humanoid Robot Market reached US$ 2.24 billion in 2024 and is expected to reach US$ 41.02 billion by 2032, growing at a CAGR of 43.83% during the forecast period of 2025 to 2032. The market is witnessing rapid expansion as advancements in artificial intelligence, machine learning, computer vision, and sensor technologies accelerate development of robots capable of mimicking human movement, interaction, and decision making. Increasing demand for automation across manufacturing, healthcare,
United States Smart Mining Market Size, Share, Growth Drivers | North America leads with 35% share | Top Companies - Hexagon AB, Komatsu Mining Corp, Cisco Systems, Inc.
United States Smart Mining Market Size, Share, Growth Drivers | North America le …
Leander, Texas and Tokyo, Japan - Feb.09.2026 As per DataM intelligence research report "Smart mining Market is anticipated to grow at a CAGR during the forecast period 2024-2031." The market is driven by digital transformation of mining operations and demand for operational efficiency. Automation, IoT sensors, and data analytics dominate adoption. Large mining companies are primary end-users. Safety improvement, cost optimization, and sustainability initiatives support market growth. Download your exclusive sample report

All 5 Releases


More Releases for CGM

Universal Adhesive Patch For CGM And Insulin Pump
Universal adhesive patch for CGM and insulin pump, waterproof breathable transparent patch, pre-cut tape, CGM protection, skin-friendly patch for 10-14 days Waterproof & Reinforced Defense - Pair it with your CGM Blood Glucose Monitoring Sensor [https://www.uwtapes.com/uw-adhesive-patch/] or TruSteel Infusion Kit while showering, bathing, exercising or swimming without worry. Protect your CGM sensor from collisions. Compatible with CGM sensors and insulin pumps [https://www.uwtapes.com/uw-adhesive-patch/] - ideal for users of closed loop systems. Suitable for
Global BGM and CGM Market Research Report 2023-2029
Blood glucose monitoring is the use of a glucose meter for testing the concentration of glucose in the blood. Particularly important in diabetes management, a blood glucose test is typically performed by piercing the skin (typically, on the finger) to draw blood, then applying the blood to a chemically active disposable 'test-strip'. The test is usually referred to as capillary blood glucose. Continuous glucose monitoring automatically tracks blood glucose levels,
Continuous Glucose Monitoring (CGM) Devices Market Higher convenience offered by …
The CGM displays a glucose trend graph and direction arrows allowing people with diabetes to anticipate approaching glucose highs and lows, thus alerting the wearer during distracted times like playing, sleeping or exercising. The CGM devices market is expected to gain a significant traction in Asia Pacific owing to the collaborations between endocrinologists, credentialed diabetes educators and stakeholder organizations for diabetes prevention. In 2017, National Diabetes Services Scheme (NDSS) initiated by
Global Continuous Glucose Monitoring Devices (CGM) Market
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Continuous Glucose Monitoring Device Market. The report analyzes the Global Continuous Glucose Monitoring Market by Component (Transmitter & receiver, sensor, Integrated Insulin Pump), By Demographics (Pediatric, Adult), By End user (Homecare, Hospital), By Region (North America, Europe, Asia Pacific, Rest of the world)
CMA CGM S. A. - Company Strategy & Performance Analysis
The research report presents a comprehensive assessment of the CMA CGM S. A. and contains thoughtful insights, facts, historical data, and statistically supported and industry validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, type of product and deal landscapes. Purchase the Report at (USD $499 only): https://www.marketinsightsreports.com/report/purchase/0926871550?mode=su?source=openpr&Mode=12                   CMA CGM
Global Continuous Glucose Monitoring (CGM) Market,
The Global Continuous Glucose Monitoring Market (CGM) was valued at US$ 444.0 million in 2015 and is projected to reach US$ 1,025.2 million by 2024, according to a new report by published by Coherent Market Insights. CGM devices allow monitoring of glucose level during bedtime, noon, pre/post lunch, or before/after exercise, which is a major factor propelling growth of the continuous glucose monitoring market. The global CGM market is undergoing a